patritumab
bezlotoxumab
iratumumab
soravtansine
anticorrelate
countercorrelated
tigatuzumab
chromobody
conatumumab
pancytokeratin
naptumomab estafenatox
-toxa-
idiospecific
antipolyvalent
-ab
reagin
antigenomic
samalizumab
immunoprobe
panitumumab
immunoinflammation
vobarilizumab
tenatumomab
ozogamicin
oleclumab
autoantibody
agonistic monoclonal antibody
agglutinin
pathoantigen
guselkumab
tabalumab
alloantibody
seroblock
bococizumab
ipilimumab
antiserum
-o-
serospecific
-a-
antiplasma
figitumumab
antiidiotypic
drozitumab
presentation
immunospecific
antigenic
acrixolimab
volociximab
vepalimomab
lucatumumab